ONCOVIN

LOE Approaching

vincristine sulfate

NDAINJECTIONINJECTABLEPriority Review
Approved
Jul 1963
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4

Clinical Trials (4)

NCT03851081Phase 1/2Withdrawn

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Started Jan 2021
0
Allogeneic Hematopoietic Stem Cell Transplantation RecipientBlasts 5 Percent or More of Bone Marrow Nucleated CellsBlasts 5 Percent or More of Peripheral Blood White Cells+5 more
NCT02072785Phase 3Unknown

Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia

Started Jun 2013
480 enrolled
Adult Acute Lymphoblastic Leukemia
NCT01171378Phase 2Completed

Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome

Started Apr 2011
43 enrolled
Richter's Syndrome
NCT00486759Phase 3Terminated

A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Started Jul 2007
787 enrolled
B-cell Lymphoma